Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
Speranza Rubattu, Silvia Mennuni, Marco Testa, et al.
International Journal of Molecular Sciences (2013) Vol. 14, Iss. 11, pp. 23011-23032
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Uric acid, indoxyl sulfate, and methylguanidine activate bulbospinal neurons in the RVLM via their specific transporters and by producing oxidative stress
Naoki Oshima, Hiroshi Onimaru, Hidehito Matsubara, et al.
Neuroscience (2015) Vol. 304, pp. 133-145
Open Access | Times Cited: 28
Oxidative stress induced by prenatal LPS leads to endothelial dysfunction and renal haemodynamic changes through angiotensin II/NADPH oxidase pathway: Prevention by early treatment with α-tocopherol
Leucio Duarte Vieira Filho, Juliane S. Farias, Diego Barbosa de Queiroz, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 12, pp. 3577-3587
Closed Access | Times Cited: 26
Range of adiposity and cardiorenal syndrome
Fernando Pazos
World Journal of Diabetes (2020) Vol. 11, Iss. 8, pp. 322-350
Open Access | Times Cited: 21
A review of the impact of oxidative stress and some antioxidant therapies on renal damage
Feliciano Tamay‐Cach, Julio César Quintana-Pérez, José G. Trujillo‐Ferrara, et al.
Renal Failure (2015) Vol. 38, Iss. 2, pp. 171-175
Open Access | Times Cited: 24
Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure
Ryo Watanabe, Jun-ichi Suzuki, Kouji Wakayama, et al.
Hypertension Research (2015) Vol. 39, Iss. 4, pp. 237-244
Open Access | Times Cited: 24
The metabolic profile of a rat model of chronic kidney disease
Yohei Tanada, Junji Okuda, Takao Kato, et al.
PeerJ (2017) Vol. 5, pp. e3352-e3352
Open Access | Times Cited: 23
Type 4 cardiorenal syndrome
Ana Luísa Pinheiro da Silva, Manuel Vaz‐da‐Silva
Revista Portuguesa de Cardiologia (2016) Vol. 35, Iss. 11, pp. 601-616
Open Access | Times Cited: 22
Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment
Marta Reina‐Couto, Joana Afonso, Jorge Carvalho, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110938-110938
Open Access | Times Cited: 20
The protective effect of Bergamot Polyphenolic Fraction on reno-cardiac damage induced by DOCA-salt and unilateral renal artery ligation in rats
Cristina Carresi, Antonio Cardamone, Anna Rita Coppoletta, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116082-116082
Open Access | Times Cited: 2
Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms
Xi Qiao, Lihua Wang, Yanhong Wang, et al.
Renal Failure (2017) Vol. 39, Iss. 1, pp. 652-659
Open Access | Times Cited: 19
Cardiorenal Syndrome Type 5:In VitroCytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile
Alessandra Brocca, Grazia Maria Virzì, Chiara Pasqualin, et al.
Analytical Cellular Pathology (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 17
Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment
Kang Fu, Yue Hu, Hui Zhang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 13
Bergamot leaf extract treats cardiorenal metabolic syndrome and associated pathophysiological factors in rats fed with a high sugar fat diet
Juliana Silva Siqueira, Taynara Aparecida Vieira, Erika Tiemi Nakandakare-Maia, et al.
Molecular and Cellular Endocrinology (2022) Vol. 556, pp. 111721-111721
Open Access | Times Cited: 9
Sestrin2 Mediates Metformin Rescued the Age-Related Cardiac Dysfunctions of Cardiorenal Syndrome Type 3
Migdalia Iglesias, Hao Wang, Meredith Krause‐Hauch, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 845-845
Open Access | Times Cited: 5
Combined therapy with melatonin and exendin-4 effectively attenuated the deterioration of renal function in rat cardiorenal syndrome.
Kuan‐Hung Chen, Chih‐Hung Chen, Christopher Glenn Wallace, et al.
PubMed (2017) Vol. 9, Iss. 2, pp. 214-229
Closed Access | Times Cited: 16
Serum oxidative stress, visfatin and apelin in healthy women and those with premenstrual syndrome
Adnan İncebıyık, Aysun Camuzcuoğlu, Neşe Gül Hilali, et al.
Journal of Obstetrics and Gynaecology (2014) Vol. 35, Iss. 2, pp. 188-192
Closed Access | Times Cited: 14
Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity
Xingxing Li, Shuangyan Li, Wen-Hui Zheng, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo
Timur I. Fetisov, А. А. Борунова, Alina S. Antipova, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 230-230
Open Access | Times Cited: 4
Bioinformatics analysis of the microRNA genes associated with type 2 cardiorenal syndrome
Yani Zong, Yuexin Hu, Mengdi Zheng, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Counteracting inflammation and insulin resistance with diet and exercise: A strategy for frailty prevention?
Giovanni Zuliani, Cecilia Soavi, Marcello Maggio, et al.
European Geriatric Medicine (2015) Vol. 6, Iss. 3, pp. 220-231
Closed Access | Times Cited: 11
MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complications
Prasanth Puthanveetil, Tony Gutschner, Johan M. Lorenzen
Hypertension Research (2019) Vol. 43, Iss. 5, pp. 372-379
Closed Access | Times Cited: 11
Targeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation
Nynke R. Oosterhuis, Lennart G. Bongartz, Marianne C. Verhaar, et al.
Acta Physiologica (2016) Vol. 220, Iss. 3, pp. 382-393
Open Access | Times Cited: 10
Mitochondrial Transplantation: Is It a Feasible Therapy to Prevent the Cardiorenal Side Effects of Cisplatin?
Isabel Amador‐Martínez, Estefani Yaquelin Hernández‐Cruz, Alexis Paulina Jiménez‐Uribe, et al.
Future Pharmacology (2021) Vol. 1, Iss. 1, pp. 3-26
Open Access | Times Cited: 10
Enhancement of renal oxidative stress by injection of angiotensin II into the paraventricular nucleus in renal ischemia–reperfusion injury
Behjat Seifi, Mehri Kadkhodaee, Enayatollah Bakhshi, et al.
Canadian Journal of Physiology and Pharmacology (2014) Vol. 92, Iss. 9, pp. 752-757
Closed Access | Times Cited: 10
Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation
Diana A. Papazova, Merle M. Krebber, Nynke R. Oosterhuis, et al.
Disease Models & Mechanisms (2018) Vol. 11, Iss. 7
Open Access | Times Cited: 10

Scroll to top